Bobbie Whiddon is presently the supervisor over the FDA imports group in Philadelphia. He has been with the FDA for almost nine years. Bobbie has acquired over 20 years of public health and environmental health experience through various positions in both government and industry.
FDA determines whether products are admissible into U.S. commerce and may refuse entry to any that violate or appear to violate any provisions of the Federal Food Drug and Cosmetic Act (FFD&C Act). Importers of products intended for introduction into U.S. interstate commerce are responsible for ensuring that the products are safe, sanitary, and labeled according to U.S. requirements. Imported products are subject to FDA inspection when offered for import at U.S. ports of entry. FDA may detain shipments of products offered for import if the shipments are found not to be in compliance with U.S. requirements. Both imported and domestically-produced foods must meet the same legal requirements in the United States.
Andreas Sonnleitner has 23 years of industry experience in the financial sector. The certified credit manager supports customers with solutions in risk management, leasing and receivables management and was already able to contribute his expertise to companies such as abcfinance and FinTecSystems in earlier years.
In 2019 Andreas joined Experian DACH as Senior Sales Manager, Finance & Payment and is primarily responsible for automotive and retail banks as well as leasing companies.
Christine McSherry founded Jett Foundation in 2001, when her son now 24-year-old Jett was diagnosed with Duchenne Muscular Dystrophy. As head of the Jett Foundation, Christine co-founded the International Duchenne Alliance, a partnership of over 40 independent organizations that has funded nearly $15 million dollars in research to date.
Christine has advocated for the patient perspective to be considered by the FDA when reviewing safe and potentially effective treatments for Duchenne. In April of 2016, Christine presented the Jett Foundation’s Patient Centered Outcomes report at the FDA’s meeting of the Peripheral and Central Nervous System Drugs Advisory Committee.
A product evangelist with 15 years of experience in the financial services industry. He has previously worked with companies like Visa, 10x Banking and Metro Bank. Currently, the Product Director at Monese, leading product propositions across Credit, Savings and Investments.
